Literature DB >> 11119271

Clinical relevance of cytokine production in HIV-1 infection in children on antiretroviral therapy.

S Resino1, J M Bellón, S Sánchez-Ramón, D Gurbindo, M A Muñóz-Fernandez.   

Abstract

In order to investigate the correlation among cytokine production and antiretroviral therapy (ART), viral load, CD4(+) and CD8(+) T lymphocytes, 55 human immunodeficiency virus (HIV)-1-infected children on ART or not, and 16 uninfected controls were studied. Peripheral blood mononuclear cells (PBMCs) of HIV-1-infected children and controls were cultured and spontaneous and mitogen-stimulated cytokines production was quantified in the supernatants. Viral load was quantified using standard molecular assay. CD4 and CD8 T-lymphocyte counts were determined by flow cytometry. Cytokine production by mitogen-stimulated PBMCs showed different profiles in HIV-1 children whether treated or not. The tumour necrosis factor (TNF)-alpha production was higher and the interleukin (IL)-10 production was lower in the HIV-1-untreated group than in the HIV-1-treated children and controls. The IL-2 production was reduced and the RANTES production was higher in both HIV-1 groups compared with the controls. The interferon (IFN)-gamma and the IL-5 production was significantly reduced in the HIV-1-treated children compared to the controls. Interestingly, the analysis of the correlation of HIV-1 phenotype with cytokine production indicated an increased RANTES production in relation to nonsyncytium-inducing viral phenotype with slow/low replication profile, whereas decreased IL-10 levels was associated to syncytium-inducing (SI) strains and rapid/high replication. Our findings suggest that AVT changes on the cytokine and chemokine production play an important role in the HIV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11119271     DOI: 10.1046/j.1365-3083.2000.00831.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Authors:  S Resino; I Galán; A Pérez; J A León; E Seoane; D Gurbindo; M Angeles Muñoz-Fernandez
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

2.  Enhanced Th17 phenotype in uninfected neonates born from viremic HIV-1-infected pregnant women.

Authors:  Joana Hygino; Morgana M Vieira; Landi V Guillermo; Renato G Silva-Filho; Carmen Saramago; Agostinho A Lima-Silva; Regis M Andrade; Arnaldao F B Andrade; Rodrigo M Brindeiro; Amilcar Tanuri; Vander Guimarães; Cleonice Alves de Melo Bento
Journal:  J Clin Immunol       Date:  2010-12-07       Impact factor: 8.317

3.  Usefulness of alternate prognostic serum and plasma markers for antiretroviral therapy for human immunodeficiency virus type 1 infection.

Authors:  R Kannangai; A J Kandathil; D L Ebenezer; E Mathai; A J Prakash; O C Abraham; T D Sudarsanam; S A Pulimood; R Selvakumar; V Job; G Sridharan
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

4.  Effect of Probiotic Supplement on Cytokine Levels in HIV-Infected Individuals: A Preliminary Study.

Authors:  Katia Falasca; Jacopo Vecchiet; Claudio Ucciferri; Marta Di Nicola; Chiara D'Angelo; Marcella Reale
Journal:  Nutrients       Date:  2015-09-28       Impact factor: 5.717

5.  Inflammatory Markers and Plasma Lipids in HIV Patients: A Correlation Analysis Study.

Authors:  Rudo Muswe; Olav Oktedalen; Danai T Zhou; Enita Zinyando; Sandra Shawarira-Bote; Babill Stray-Pedersen; Atipa Siziba; Zvenyika A R Gomo
Journal:  Open Biochem J       Date:  2017-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.